Показати простий запис статті
dc.contributor.author |
Giesel, F.L. |
|
dc.contributor.author |
Mehndiratta, A. |
|
dc.contributor.author |
Mafomane, M.P. |
|
dc.contributor.author |
Zechmann, C.M. |
|
dc.contributor.author |
Bergmann, F. |
|
dc.contributor.author |
Schemmer, P. |
|
dc.contributor.author |
Haberkorn, U. |
|
dc.contributor.author |
Kratochwil, C. |
|
dc.date.accessioned |
2018-06-19T11:44:50Z |
|
dc.date.available |
2018-06-19T11:44:50Z |
|
dc.date.issued |
2012 |
|
dc.identifier.citation |
Cancer with unknown primary: finding a needle in a hay stack / F.L. Giesel, A. Mehndiratta, M.P. Mafomane, C.M. Zechmann, F. Bergmann, P. Schemmer, U. Haberkorn, C. Kratochwil // Experimental Oncology. — 2012. — Т. 34, № 1. — С. 64-65. — Бібліогр.: 6 назв. — англ. |
uk_UA |
dc.identifier.issn |
1812-9269 |
|
dc.identifier.uri |
http://dspace.nbuv.gov.ua/handle/123456789/138693 |
|
dc.description.abstract |
Detection and resection of small neuroendocrine tumours (NET) is like finding a needle in a hay stack. Use of specific tracers such as 68Ga-DOTATOC in a PET/CT study has been proven to have a high sensitivity and specificity to cells expressing somatostatin-SSR receptors. The use of 99mTc-Octreotide to detect neuroendocrine tumours during surgery is an effective adjunct for therapy. We here present a clinical case of patient with NET where these modalities help in both diagnostic and therapeutic surgery. |
uk_UA |
dc.language.iso |
en |
uk_UA |
dc.publisher |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
uk_UA |
dc.relation.ispartof |
Experimental Oncology |
|
dc.subject |
Case report |
uk_UA |
dc.title |
Cancer with unknown primary: finding a needle in a hay stack |
uk_UA |
dc.type |
Article |
uk_UA |
dc.status |
published earlier |
uk_UA |
Файли у цій статті
Ця стаття з'являється у наступних колекціях
Показати простий запис статті